Thu, January 9, 2025
Wed, January 8, 2025
Tue, January 7, 2025
[ Tue, Jan 07th 2025 ]: Indiatimes
Here are trends in GCCs
[ Tue, Jan 07th 2025 ]: CNET
Top Wellness Trends to Watch in 2025
Mon, January 6, 2025

Vir jumps after Phase 1 data for Sanofi-partnered cancer drug technology

The article from MSN discusses Vir Biotechnology's significant stock price increase following the release of promising Phase 1 data for their cancer drug technology, developed in partnership with Sanofi. The drug, VIR-2482, targets the T cell immunoglobulin and mucin domain-3 (TIM-3) receptor, which is involved in immune response regulation. The preliminary results showed that VIR-2482 was well-tolerated and demonstrated biological activity, suggesting potential effectiveness in treating various cancers by enhancing the immune system's ability to fight tumors. This development has not only boosted investor confidence but also highlighted the potential of Vir's innovative approach in immunotherapy, leading to a surge in its stock value.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/science/biochemistry/vir-jumps-after-phase-1-data-for-sanofi-partnered-cancer-drug-technology/ar-AA1xaULT ]


Similar Science and Technology Publications